SWOG S2210: A Phase II Study of Neoadjuvant Carboplatin for Localized, High-Risk Prostate Cancer with Germline BRCA1/2 Mutations.
Journal of Clinical Oncology（2024）
Key words
261-492-5651-2790,613-4678-146-349,261-3278,281-5277-5594,613-545-230,613-615-646-3281-7408-2399,283-183-180-5583,295,295,38092-29068,38092-25779,38092-18853,38092-18852
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined